When: Confirmed close above $223.37 with volume >5M shares

Then: Scale to 2% position

When: $223.37 holds as new support after breakout

Then: Add 1%

HOLD

• Forward P/E of 9.05 and PEG of 0.23 are only valid if Forward EPS of $24.05 materializes; Q1-Q2 2026 quarterly prints ($3.34 and $4.73) suggest annualized $16-18, not $24
• A 25% rally from $174.24 to $217.76 with no meaningful pullback indicates a stretched, vulnerable move rather than sustainable strength
• RSI making a lower high while price makes a higher high constitutes bearish divergence—a leading warning signal, not a healthy reset
• Breakout to $259.64 faces multiple resistance zones: Bollinger upper band at $223.37, August highs $222-$228, and descending trendline $235-$245
• Downside below $206.52 (200 SMA) risks 8-10% in stress scenarios given ATR of $5.58 (2.6% daily volatility) and bank headline risk
• Goodwill of $31.9 billion represents 32% of stockholders' equity; impairment hits book value and signals to market that Discover purchase price was overstated
• Legacy Discover volume growth under 2% raises concerns about synergy realization and goodwill recoverability despite 26% blended volume growth
• Trump Organization AML lawsuit timeline extends into 2027 with ongoing headline risk and potential discovery of other politically sensitive account closures
• Aggressive Analyst's full-position recommendation on volume breakout is FOMO-driven; scaling in 2-3% preserves upside while limiting drawdown on failed signals
• Proper entry zone is $210-$215 with stop at $206.52; this disciplined framework protects capital through scenarios that cannot yet be seen

→ vs aggressive: Forward EPS estimate of $24.05 implies ~33% earnings growth but quarterly results suggest $16-18 annualized; post-merger consensus estimates are systematically optimistic for 18-24 months, making the valuation case fragile rather than compelling

→ vs aggressive: A 25% two-month rally with no pullback is technically stretched and vulnerable, not a sign of strength; framing this as bullish encourages buying at tops

→ vs aggressive: RSI failing to confirm new price highs is textbook bearish divergence—a leading indicator specifically designed to flag these conditions, not a non-event to explain away

→ vs aggressive: Path to $259.64 is not unimpeded; multiple resistance zones exist ($223.37 Bollinger band, $222-228 August highs, $235-245 descending trendline), while downside risk is understated at 5% given ATR and gap risk

→ vs aggressive: Polymarket's 8% recession odds capture broad recession probability but not credit deterioration; subprime credit lag risk exists independently of recession scenarios

→ vs aggressive: While COF can absorb a goodwill writedown given $54.7B cash and $113.8B equity, the stock multiple compresses when impairment is taken—this is beside the point of whether impairment signals overpayment for Discover

→ vs aggressive: Legacy Discover under 2% volume growth directly affects synergy realization and goodwill recoverability; the franchise COF paid premium for is not expanding

→ vs aggressive: Trump Organization AML lawsuit extends into 2027 with 18 months of headline risk; legal discovery could expand reputational surface area beyond current scope

→ vs aggressive: Recommending full position commitment on breakout above $223.37 with 5M+ volume is reckless; breakouts fail and full commitment on a failed signal forces meaningful drawdown or forced selling at loss

HOLD

• Aggressive Analyst overreaches by building the bull case on $24.05 Forward EPS, which is optimistic; realistic range is $20-$22, still compelling but not extreme
• Conservative Analyst overreaches on bearish RSI divergence as a reversal signal—false positive rate is high in strong uptrends; divergence signals elevated pullback probability, not imminent reversal
• V-shaped recovery of 25% in two months without a 5% pullback elevates statistical probability of near-term consolidation, not reversal
• Aggressive's 'commit full position' at $223.37 breakout is the single biggest risk in the analysis; buying highest volatility with maximum capital is poor risk management
• Credit risk is real but not alarming: Q2 net income of $3 billion and FCF of $8 billion show COF managing through; provisions for credit losses should be monitored closely
• Goodwill impairment is already priced into the multiple at P/B of 1.30x, which is below pre-merger levels; impairment would confirm existing skepticism, not introduce new risk
• Trump lawsuit creates low-probability, high-impact headline risk through 2027; argues for smaller position sizing, not abandonment
• Recommended tiered scale-in: 1.5% at $213-$215 pullback as starter, add 1-1.5% on confirmation; 2% on breakout above $223.37 with volume >5M, add 1% on retest as support
• Stop level at $206.52 is appropriate; tighten to $215 once in position for trailing stop management
• Hedging with put options at $210 strike for 60-90 days recommended given credit and litigation binary risks

→ vs aggressive: Full commitment at $223.37 breakout is the single biggest risk—buying highest volatility with maximum capital exposure creates worst outcomes when breakouts fail, which happens more often than admitted

→ vs aggressive: Forward EPS of $24.05 is the weakest link in the bull case; post-merger consensus is systematically optimistic for 18-24 months; realistic $20-$22 still supports valuation but not 'screaming mispricing' framing

→ vs conservative: Bearish divergence as a clear reversal signal is too definitive; it signals elevated pullback probability, not imminent reversal—divergence present since August 4 with price still at $217.76 without meaningful reversal

→ vs conservative: Calling the case 'fragile' overreaches; COF is not fragile, it just isn't as cheap as the most aggressive forecast suggests; P/B of 1.30x and Q2 metrics ($3B net income, $8B FCF) show resilience

→ vs conservative: Credit deterioration and recession are not the same thing; Polymarket's 8% recession odds suggests benign macro backdrop, though subprime exposure warrants monitoring provisions